Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Lacquaniti

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 2, 2014
[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)]Antonio Lacquaniti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 22, 2012
[Hyponatremia in hospitalized patients: an underestimated problem]Antonio Lacquaniti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 1, 2011
[Malnutrition-inflammation syndrome in dialysis: in search of new biomarkers]Antonio Lacquaniti
Journal of Clinical Medicine|December 23, 2022
Acute Kidney Injury: Advances in Clinical ManagementAntonio Lacquaniti, Paolo Monardo
Pediatric Nephrology (Berlin, Germany)|March 23, 2022
Response to: Urine bikunin and kidney involvement in Fabry diseaseRoberto Chimenz, Antonio Lacquaniti
Radiology|December 7, 2013
ResponseAntonio Lacquaniti, Michele Buemi
Journal of Clinical Medicine|July 27, 2022
Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced TechnologiesPaolo Monardo, Antonio Lacquaniti
Critical Care Medicine|October 30, 2009
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement?Davide Bolignano, Giuseppe Coppolino, Antonio Lacquaniti, et al.
Journal of Clinical Medicine|July 9, 2022
Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same CoinSusanna Campo, Antonio Lacquaniti, Domenico Trombetta, et al.
Annals of Nutrition & Metabolism|December 14, 2011
Obestatin: an interesting but controversial gut hormoneAntonio Lacquaniti, Valentina Donato, Valeria Chirico, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 2, 2014
[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)]Antonio Lacquaniti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 22, 2012
[Hyponatremia in hospitalized patients: an underestimated problem]Antonio Lacquaniti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 1, 2011
[Malnutrition-inflammation syndrome in dialysis: in search of new biomarkers]Antonio Lacquaniti
Journal of Clinical Medicine|December 23, 2022
Acute Kidney Injury: Advances in Clinical ManagementAntonio Lacquaniti, Paolo Monardo
Pediatric Nephrology (Berlin, Germany)|March 23, 2022
Response to: Urine bikunin and kidney involvement in Fabry diseaseRoberto Chimenz, Antonio Lacquaniti
Radiology|December 7, 2013
ResponseAntonio Lacquaniti, Michele Buemi
Journal of Clinical Medicine|July 27, 2022
Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced TechnologiesPaolo Monardo, Antonio Lacquaniti
Critical Care Medicine|October 30, 2009
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement?Davide Bolignano, Giuseppe Coppolino, Antonio Lacquaniti, et al.
Journal of Clinical Medicine|July 9, 2022
Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same CoinSusanna Campo, Antonio Lacquaniti, Domenico Trombetta, et al.
Annals of Nutrition & Metabolism|December 14, 2011
Obestatin: an interesting but controversial gut hormoneAntonio Lacquaniti, Valentina Donato, Valeria Chirico, et al.
Pageof 11